Stanley Capital Management’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.14M Sell
252,000
-150,000
-37% -$3.68M 0.69% 40
2025
Q4
$11.5M Buy
402,000
+25,000
+7% +$677K 1.92% 24
2025
Q3
$11.1M Hold
377,000
1.83% 25
2025
Q2
$10.9M Buy
377,000
+32,000
+9% +$946K 1.83% 25
2025
Q1
$12.1M Buy
345,000
+150,000
+77% +$6.12M 2.37% 21
2024
Q4
$8.69M Buy
+195,000
New +$7.98M 1.69% 29

Other funds holding QDEL

Stanley Capital Management's QDEL Position: Q1 2026 in Review

Stanley Capital Management reduced its QuidelOrtho (QDEL) stake by 37% in Q1 2026, selling an estimated $3.68M and leaving 252,000 shares worth $4.14M. The position accounts for 0.69% of the portfolio, ranked #40.

Stanley Capital Management first reported a position in QDEL in Q4 2024 and has held it in 6 quarters since. The position peaked at $12.1M in Q1 2025. 237 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

  • Stanley Capital Management held 252,000 shares of QuidelOrtho worth $4.14M as of Q1 2026.
  • Stanley Capital Management sold 150,000 QuidelOrtho shares in Q1 2026, an estimated $3.68M.
  • QuidelOrtho made up 0.69% of Stanley Capital Management's portfolio in Q1 2026, its #40 holding.
  • Stanley Capital Management first reported a position in QuidelOrtho in Q4 2024 and has held it in 6 quarters since.
  • Stanley Capital Management's QuidelOrtho position peaked at $12.1M in Q1 2025.
  • 237 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on Stanley Capital Management's 13F filing for Q1 2026, filed 12 May 2026.